Woodward, Inc.

**Signal Note: Driehaus Capital initiates $21.4M position in Woodward, Inc.** This represents a notable entry by a growth-focused biotech allocator into WWD, an aerospace/defense and specialty chemicals manufacturer—not a pure-play biotech. The signal likely reflects confidence in Woodward's specialty pharmaceutical chemicals and advanced materials segments rather than a clinical-stage drug catalyst. Investors should clarify whether this signals conviction in specific pharma supply chain opportunities or represents portfolio diversification into adjacent sectors.